2020
DOI: 10.1016/j.preghy.2020.09.006
|View full text |Cite
|
Sign up to set email alerts
|

Why magnesium sulfate ‘coverage’ only is not enough to reduce eclampsia: Lessons learned in a middle-income country

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 32 publications
0
1
0
1
Order By: Relevance
“…Finally, group 10 (women with preterm, single cephalic pregnancy) was the second largest contributor to CS. Previous research in Suriname has highlighted the significant prevalence of hypertensive disorders of pregnancy and its profound effect on adverse perinatal outcomes, which could potentially affect the extent to which group 10 contributes to CS rates in the country [41,42]. Prevention, early detection, and adequate treatment of HDP could therefore potentially contribute to reducing preterm CS in Suriname [21].…”
Section: Adverse Neonatal Outcomesmentioning
confidence: 99%
“…Finally, group 10 (women with preterm, single cephalic pregnancy) was the second largest contributor to CS. Previous research in Suriname has highlighted the significant prevalence of hypertensive disorders of pregnancy and its profound effect on adverse perinatal outcomes, which could potentially affect the extent to which group 10 contributes to CS rates in the country [41,42]. Prevention, early detection, and adequate treatment of HDP could therefore potentially contribute to reducing preterm CS in Suriname [21].…”
Section: Adverse Neonatal Outcomesmentioning
confidence: 99%
“…Por su parte la eclampsia en estas pacientes está relacionadas con trastornos hipertensivos del embarazo, vista como una complicación grave y potencialmente mortal que provoca una morbimortalidad significativa (17; 21 -25). Se concuerda con el autor Carrera (2020), quien aprecia la prevalencia de varias complicaciones maternofetales que elevan la morbimortalidad de las embarazadas (31), así como, otros estudios que reconocen la eclampsia dentro de las principales problemáticas del embarazo a nivel mundial, con una tasa de letalidad de hasta el 10 % en países de bajos ingresos (32).…”
Section: Artículo Originalunclassified